Global DNA and Gene Chip

DNA and Gene Chip Comprehensive Study by Type (Oligonucleotide Based Chips {Photolithographic Oligonucleotide Chips, Inkjet Print Technology Generated Oligonucleotide Chips}, CDNA Chips {Mechanical Microspotting Generated cDNA Chips, Inkjet Print Technology Generated cDNA Chips}), Application (Gene Expression, SNP Analysis, Cancer Diagnosis & Treatment, Genomics, Proteomics, Agricultural Biology, Environmental Control, Toxicogenomics, Drug Discovery, Screening & Monitoring of Patient Data in Clinical Trials, Microbial Genotyping), End Users (Academic & Research Institutes, Biotechnological & Pharmaceutical Companies, Research Laboratories), Offerings (Instruments, Software, Others) Players and Region - Global Market Outlook to 2028

DNA and Gene Chip Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
The DNA and Gene Chip provides a systems biology outlook for both expression profiling and DNA analysis. It is an integrated system that provides high flexibility for the genome at the global level. The major advantages of gene chips include the power of the probe set, Multiple applications for the genomic perspective, parallel manufacturing, and open access. It is products and custom options for RNA and DNA applications majorly for the Flexible array formats for the freedom to conduct whole-genome analysis.This growth is primarily driven by Increasing Initiatives Related to the DNA or Gene is Driving the Growth of the Market .

AttributesDetails
Study Period2018-2028
Base Year2022
Forecast Period2023-2028
Volume UnitK Units
Value UnitUSD (Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


The Biotechnology sector in the region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Affymetrix Inc. (United States), Agilent Technologies Inc. (United States), Biomieux Sa (France), Biometrix Technology Inc. (Korea), Bioneer Corp (South Korea), Capitalbio Corp (China), Eurofins Scientific (Eurofins Mwg Operon) (Luxembourg), Greiner Bio-One (Austria), Illumina Inc. (United States) and LC Sciences (United States), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:
In February 2023, Curio Bioscience emerged from stealth earlier this month with the launch of its Seeker platform, an "industrial grade" version of Slide-seq, a whole-transcriptome spatial genomics method developed by Fei Chen's lab at the Broad Institute.
In Jan 2020, EVONETIX Ltd. The company announced the partnership with imec to enhance the production of the microelectromechanical systems (MEMS)-based silicon chips. Through this step, the company can cater to the rapidly growing field of synthetic biology.The companies operate in this industry are focusing on technology development and others. There is intense competition in this industry, there is some new market entrants are also there. To become the market leaders the players are focusing on enhancing their footprint across the globe.

Influencing Trend:
Advancements in the Area of Diagnostics and Use of Genomic Data and Growing Demand of the Real-Time PCR Has Raised as the Most Popularly One

Market Growth Drivers:
Increasing Initiatives Related to the DNA or Gene is Driving the Growth of the Market, High Requirement for Initial Cancer Detection & Cancer Diagnosis Across the Globe, DNA/Gene Chips Modification is Fast-Tracking the Market in the Future and Increasing Government Funding in Biotechnology

Challenges:
High Complexity of Microarrays in Comparison of the Other Sequencing Technologies in Terms of Data Interpretation and Sample Preparation Which Also Limit the Market Growth

Restraints:
Increase Presence of Substitute Technologies Which is Hampering the Market of Growth and Lack of Technical & Skilled Employees

Opportunities:
Increasing Use of Microarrays While Making Personalized Medicine

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mainly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the market's growth. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Data Sources of DNA and Gene Chip Market Study

Primary Collection: InMail, LinkedIn Groups, Survey Monkey, Google, and Other professional Forums are some of the mediums utilized to gather primary data through key industry participants and appointees, subject-matter experts, C-level executives of DNA and Gene Chip Industry, among others including independent industry consultants, experts, to obtain and verify critical qualitative commentary and opinion and quantitative statistics, to assess future market prospects.

The primary interviews and data collected as per the below protocols:
• By Designation: C-Level, D-Level, Others
• By Company Type: Tier 1, Tier 2, Tier 3

Secondary Data Sources such as Annual reports, Press releases, Analyst meetings, Conference calls, Investor presentations, Management statements, and SEC filings of DNA and Gene Chip players along with Regulatory Sites, Association, World bank, etc were used as sources secondary set of data.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, DNA and Gene Chip Study Sheds Light on
— The DNA and Gene Chip Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the DNA and Gene Chip industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where DNA and Gene Chip industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Oligonucleotide Based Chips {Photolithographic Oligonucleotide Chips, Inkjet Print Technology Generated Oligonucleotide Chips}
  • cDNA Chips {Mechanical Microspotting Generated cDNA Chips, Inkjet Print Technology Generated cDNA Chips}
By Application
  • Gene Expression
  • SNP Analysis
  • Cancer Diagnosis & Treatment
  • Genomics
  • Proteomics
  • Agricultural Biology
  • Environmental Control
  • Toxicogenomics
  • Drug Discovery
  • Screening & Monitoring of Patient Data in Clinical Trials
  • Microbial Genotyping
By End Users
  • Academic & Research Institutes
  • Biotechnological & Pharmaceutical Companies
  • Research Laboratories

By Offerings
  • Instruments
  • Software
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Initiatives Related to the DNA or Gene is Driving the Growth of the Market
      • 3.2.2. High Requirement for Initial Cancer Detection & Cancer Diagnosis Across the Globe
      • 3.2.3. DNA/Gene Chips Modification is Fast-Tracking the Market in the Future
      • 3.2.4. Increasing Government Funding in Biotechnology
    • 3.3. Market Challenges
      • 3.3.1. High Complexity of Microarrays in Comparison of the Other Sequencing Technologies in Terms of Data Interpretation and Sample Preparation Which Also Limit the Market Growth
    • 3.4. Market Trends
      • 3.4.1. Advancements in the Area of Diagnostics and Use of Genomic Data
      • 3.4.2. Growing Demand of the Real-Time PCR Has Raised as the Most Popularly One
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global DNA and Gene Chip, by Type, Application, End Users, Offerings and Region (value, volume and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global DNA and Gene Chip (Value)
      • 5.2.1. Global DNA and Gene Chip by: Type (Value)
        • 5.2.1.1. Oligonucleotide Based Chips {Photolithographic Oligonucleotide Chips, Inkjet Print Technology Generated Oligonucleotide Chips}
        • 5.2.1.2. CDNA Chips {Mechanical Microspotting Generated cDNA Chips, Inkjet Print Technology Generated cDNA Chips}
      • 5.2.2. Global DNA and Gene Chip by: Application (Value)
        • 5.2.2.1. Gene Expression
        • 5.2.2.2. SNP Analysis
        • 5.2.2.3. Cancer Diagnosis & Treatment
        • 5.2.2.4. Genomics
        • 5.2.2.5. Proteomics
        • 5.2.2.6. Agricultural Biology
        • 5.2.2.7. Environmental Control
        • 5.2.2.8. Toxicogenomics
        • 5.2.2.9. Drug Discovery
        • 5.2.2.10. Screening & Monitoring of Patient Data in Clinical Trials
        • 5.2.2.11. Microbial Genotyping
      • 5.2.3. Global DNA and Gene Chip by: End Users (Value)
        • 5.2.3.1. Academic & Research Institutes
        • 5.2.3.2. Biotechnological & Pharmaceutical Companies
        • 5.2.3.3. Research Laboratories
      • 5.2.4. Global DNA and Gene Chip by: Offerings (Value)
        • 5.2.4.1. Instruments
        • 5.2.4.2. Software
        • 5.2.4.3. Others
      • 5.2.5. Global DNA and Gene Chip Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global DNA and Gene Chip (Volume)
      • 5.3.1. Global DNA and Gene Chip by: Type (Volume)
        • 5.3.1.1. Oligonucleotide Based Chips {Photolithographic Oligonucleotide Chips, Inkjet Print Technology Generated Oligonucleotide Chips}
        • 5.3.1.2. CDNA Chips {Mechanical Microspotting Generated cDNA Chips, Inkjet Print Technology Generated cDNA Chips}
      • 5.3.2. Global DNA and Gene Chip by: Application (Volume)
        • 5.3.2.1. Gene Expression
        • 5.3.2.2. SNP Analysis
        • 5.3.2.3. Cancer Diagnosis & Treatment
        • 5.3.2.4. Genomics
        • 5.3.2.5. Proteomics
        • 5.3.2.6. Agricultural Biology
        • 5.3.2.7. Environmental Control
        • 5.3.2.8. Toxicogenomics
        • 5.3.2.9. Drug Discovery
        • 5.3.2.10. Screening & Monitoring of Patient Data in Clinical Trials
        • 5.3.2.11. Microbial Genotyping
      • 5.3.3. Global DNA and Gene Chip by: End Users (Volume)
        • 5.3.3.1. Academic & Research Institutes
        • 5.3.3.2. Biotechnological & Pharmaceutical Companies
        • 5.3.3.3. Research Laboratories
      • 5.3.4. Global DNA and Gene Chip by: Offerings (Volume)
        • 5.3.4.1. Instruments
        • 5.3.4.2. Software
        • 5.3.4.3. Others
      • 5.3.5. Global DNA and Gene Chip Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global DNA and Gene Chip (Price)
      • 5.4.1. Global DNA and Gene Chip by: Type (Price)
  • 6. DNA and Gene Chip: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Affymetrix Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Agilent Technologies Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Biomieux Sa (France)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Biometrix Technology Inc. (Korea)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Bioneer Corp (South Korea)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Capitalbio Corp (China)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Eurofins Scientific (Eurofins Mwg Operon) (Luxembourg)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Greiner Bio-One (Austria)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Illumina Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. LC Sciences (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global DNA and Gene Chip Sale, by Type, Application, End Users, Offerings and Region (value, volume and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global DNA and Gene Chip (Value)
      • 7.2.1. Global DNA and Gene Chip by: Type (Value)
        • 7.2.1.1. Oligonucleotide Based Chips {Photolithographic Oligonucleotide Chips, Inkjet Print Technology Generated Oligonucleotide Chips}
        • 7.2.1.2. CDNA Chips {Mechanical Microspotting Generated cDNA Chips, Inkjet Print Technology Generated cDNA Chips}
      • 7.2.2. Global DNA and Gene Chip by: Application (Value)
        • 7.2.2.1. Gene Expression
        • 7.2.2.2. SNP Analysis
        • 7.2.2.3. Cancer Diagnosis & Treatment
        • 7.2.2.4. Genomics
        • 7.2.2.5. Proteomics
        • 7.2.2.6. Agricultural Biology
        • 7.2.2.7. Environmental Control
        • 7.2.2.8. Toxicogenomics
        • 7.2.2.9. Drug Discovery
        • 7.2.2.10. Screening & Monitoring of Patient Data in Clinical Trials
        • 7.2.2.11. Microbial Genotyping
      • 7.2.3. Global DNA and Gene Chip by: End Users (Value)
        • 7.2.3.1. Academic & Research Institutes
        • 7.2.3.2. Biotechnological & Pharmaceutical Companies
        • 7.2.3.3. Research Laboratories
      • 7.2.4. Global DNA and Gene Chip by: Offerings (Value)
        • 7.2.4.1. Instruments
        • 7.2.4.2. Software
        • 7.2.4.3. Others
      • 7.2.5. Global DNA and Gene Chip Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global DNA and Gene Chip (Volume)
      • 7.3.1. Global DNA and Gene Chip by: Type (Volume)
        • 7.3.1.1. Oligonucleotide Based Chips {Photolithographic Oligonucleotide Chips, Inkjet Print Technology Generated Oligonucleotide Chips}
        • 7.3.1.2. CDNA Chips {Mechanical Microspotting Generated cDNA Chips, Inkjet Print Technology Generated cDNA Chips}
      • 7.3.2. Global DNA and Gene Chip by: Application (Volume)
        • 7.3.2.1. Gene Expression
        • 7.3.2.2. SNP Analysis
        • 7.3.2.3. Cancer Diagnosis & Treatment
        • 7.3.2.4. Genomics
        • 7.3.2.5. Proteomics
        • 7.3.2.6. Agricultural Biology
        • 7.3.2.7. Environmental Control
        • 7.3.2.8. Toxicogenomics
        • 7.3.2.9. Drug Discovery
        • 7.3.2.10. Screening & Monitoring of Patient Data in Clinical Trials
        • 7.3.2.11. Microbial Genotyping
      • 7.3.3. Global DNA and Gene Chip by: End Users (Volume)
        • 7.3.3.1. Academic & Research Institutes
        • 7.3.3.2. Biotechnological & Pharmaceutical Companies
        • 7.3.3.3. Research Laboratories
      • 7.3.4. Global DNA and Gene Chip by: Offerings (Volume)
        • 7.3.4.1. Instruments
        • 7.3.4.2. Software
        • 7.3.4.3. Others
      • 7.3.5. Global DNA and Gene Chip Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global DNA and Gene Chip (Price)
      • 7.4.1. Global DNA and Gene Chip by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. DNA and Gene Chip: by Type(USD Million)
  • Table 2. DNA and Gene Chip Oligonucleotide Based Chips {Photolithographic Oligonucleotide Chips, Inkjet Print Technology Generated Oligonucleotide Chips} , by Region USD Million (2017-2022)
  • Table 3. DNA and Gene Chip CDNA Chips {Mechanical Microspotting Generated cDNA Chips, Inkjet Print Technology Generated cDNA Chips} , by Region USD Million (2017-2022)
  • Table 4. DNA and Gene Chip: by Application(USD Million)
  • Table 5. DNA and Gene Chip Gene Expression , by Region USD Million (2017-2022)
  • Table 6. DNA and Gene Chip SNP Analysis , by Region USD Million (2017-2022)
  • Table 7. DNA and Gene Chip Cancer Diagnosis & Treatment , by Region USD Million (2017-2022)
  • Table 8. DNA and Gene Chip Genomics , by Region USD Million (2017-2022)
  • Table 9. DNA and Gene Chip Proteomics , by Region USD Million (2017-2022)
  • Table 10. DNA and Gene Chip Agricultural Biology , by Region USD Million (2017-2022)
  • Table 11. DNA and Gene Chip Environmental Control , by Region USD Million (2017-2022)
  • Table 12. DNA and Gene Chip Toxicogenomics , by Region USD Million (2017-2022)
  • Table 13. DNA and Gene Chip Drug Discovery , by Region USD Million (2017-2022)
  • Table 14. DNA and Gene Chip Screening & Monitoring of Patient Data in Clinical Trials , by Region USD Million (2017-2022)
  • Table 15. DNA and Gene Chip Microbial Genotyping , by Region USD Million (2017-2022)
  • Table 16. DNA and Gene Chip: by End Users(USD Million)
  • Table 17. DNA and Gene Chip Academic & Research Institutes , by Region USD Million (2017-2022)
  • Table 18. DNA and Gene Chip Biotechnological & Pharmaceutical Companies , by Region USD Million (2017-2022)
  • Table 19. DNA and Gene Chip Research Laboratories , by Region USD Million (2017-2022)
  • Table 20. DNA and Gene Chip: by Offerings(USD Million)
  • Table 21. DNA and Gene Chip Instruments , by Region USD Million (2017-2022)
  • Table 22. DNA and Gene Chip Software , by Region USD Million (2017-2022)
  • Table 23. DNA and Gene Chip Others , by Region USD Million (2017-2022)
  • Table 24. South America DNA and Gene Chip, by Country USD Million (2017-2022)
  • Table 25. South America DNA and Gene Chip, by Type USD Million (2017-2022)
  • Table 26. South America DNA and Gene Chip, by Application USD Million (2017-2022)
  • Table 27. South America DNA and Gene Chip, by End Users USD Million (2017-2022)
  • Table 28. South America DNA and Gene Chip, by Offerings USD Million (2017-2022)
  • Table 29. Brazil DNA and Gene Chip, by Type USD Million (2017-2022)
  • Table 30. Brazil DNA and Gene Chip, by Application USD Million (2017-2022)
  • Table 31. Brazil DNA and Gene Chip, by End Users USD Million (2017-2022)
  • Table 32. Brazil DNA and Gene Chip, by Offerings USD Million (2017-2022)
  • Table 33. Argentina DNA and Gene Chip, by Type USD Million (2017-2022)
  • Table 34. Argentina DNA and Gene Chip, by Application USD Million (2017-2022)
  • Table 35. Argentina DNA and Gene Chip, by End Users USD Million (2017-2022)
  • Table 36. Argentina DNA and Gene Chip, by Offerings USD Million (2017-2022)
  • Table 37. Rest of South America DNA and Gene Chip, by Type USD Million (2017-2022)
  • Table 38. Rest of South America DNA and Gene Chip, by Application USD Million (2017-2022)
  • Table 39. Rest of South America DNA and Gene Chip, by End Users USD Million (2017-2022)
  • Table 40. Rest of South America DNA and Gene Chip, by Offerings USD Million (2017-2022)
  • Table 41. Asia Pacific DNA and Gene Chip, by Country USD Million (2017-2022)
  • Table 42. Asia Pacific DNA and Gene Chip, by Type USD Million (2017-2022)
  • Table 43. Asia Pacific DNA and Gene Chip, by Application USD Million (2017-2022)
  • Table 44. Asia Pacific DNA and Gene Chip, by End Users USD Million (2017-2022)
  • Table 45. Asia Pacific DNA and Gene Chip, by Offerings USD Million (2017-2022)
  • Table 46. China DNA and Gene Chip, by Type USD Million (2017-2022)
  • Table 47. China DNA and Gene Chip, by Application USD Million (2017-2022)
  • Table 48. China DNA and Gene Chip, by End Users USD Million (2017-2022)
  • Table 49. China DNA and Gene Chip, by Offerings USD Million (2017-2022)
  • Table 50. Japan DNA and Gene Chip, by Type USD Million (2017-2022)
  • Table 51. Japan DNA and Gene Chip, by Application USD Million (2017-2022)
  • Table 52. Japan DNA and Gene Chip, by End Users USD Million (2017-2022)
  • Table 53. Japan DNA and Gene Chip, by Offerings USD Million (2017-2022)
  • Table 54. India DNA and Gene Chip, by Type USD Million (2017-2022)
  • Table 55. India DNA and Gene Chip, by Application USD Million (2017-2022)
  • Table 56. India DNA and Gene Chip, by End Users USD Million (2017-2022)
  • Table 57. India DNA and Gene Chip, by Offerings USD Million (2017-2022)
  • Table 58. South Korea DNA and Gene Chip, by Type USD Million (2017-2022)
  • Table 59. South Korea DNA and Gene Chip, by Application USD Million (2017-2022)
  • Table 60. South Korea DNA and Gene Chip, by End Users USD Million (2017-2022)
  • Table 61. South Korea DNA and Gene Chip, by Offerings USD Million (2017-2022)
  • Table 62. Taiwan DNA and Gene Chip, by Type USD Million (2017-2022)
  • Table 63. Taiwan DNA and Gene Chip, by Application USD Million (2017-2022)
  • Table 64. Taiwan DNA and Gene Chip, by End Users USD Million (2017-2022)
  • Table 65. Taiwan DNA and Gene Chip, by Offerings USD Million (2017-2022)
  • Table 66. Australia DNA and Gene Chip, by Type USD Million (2017-2022)
  • Table 67. Australia DNA and Gene Chip, by Application USD Million (2017-2022)
  • Table 68. Australia DNA and Gene Chip, by End Users USD Million (2017-2022)
  • Table 69. Australia DNA and Gene Chip, by Offerings USD Million (2017-2022)
  • Table 70. Rest of Asia-Pacific DNA and Gene Chip, by Type USD Million (2017-2022)
  • Table 71. Rest of Asia-Pacific DNA and Gene Chip, by Application USD Million (2017-2022)
  • Table 72. Rest of Asia-Pacific DNA and Gene Chip, by End Users USD Million (2017-2022)
  • Table 73. Rest of Asia-Pacific DNA and Gene Chip, by Offerings USD Million (2017-2022)
  • Table 74. Europe DNA and Gene Chip, by Country USD Million (2017-2022)
  • Table 75. Europe DNA and Gene Chip, by Type USD Million (2017-2022)
  • Table 76. Europe DNA and Gene Chip, by Application USD Million (2017-2022)
  • Table 77. Europe DNA and Gene Chip, by End Users USD Million (2017-2022)
  • Table 78. Europe DNA and Gene Chip, by Offerings USD Million (2017-2022)
  • Table 79. Germany DNA and Gene Chip, by Type USD Million (2017-2022)
  • Table 80. Germany DNA and Gene Chip, by Application USD Million (2017-2022)
  • Table 81. Germany DNA and Gene Chip, by End Users USD Million (2017-2022)
  • Table 82. Germany DNA and Gene Chip, by Offerings USD Million (2017-2022)
  • Table 83. France DNA and Gene Chip, by Type USD Million (2017-2022)
  • Table 84. France DNA and Gene Chip, by Application USD Million (2017-2022)
  • Table 85. France DNA and Gene Chip, by End Users USD Million (2017-2022)
  • Table 86. France DNA and Gene Chip, by Offerings USD Million (2017-2022)
  • Table 87. Italy DNA and Gene Chip, by Type USD Million (2017-2022)
  • Table 88. Italy DNA and Gene Chip, by Application USD Million (2017-2022)
  • Table 89. Italy DNA and Gene Chip, by End Users USD Million (2017-2022)
  • Table 90. Italy DNA and Gene Chip, by Offerings USD Million (2017-2022)
  • Table 91. United Kingdom DNA and Gene Chip, by Type USD Million (2017-2022)
  • Table 92. United Kingdom DNA and Gene Chip, by Application USD Million (2017-2022)
  • Table 93. United Kingdom DNA and Gene Chip, by End Users USD Million (2017-2022)
  • Table 94. United Kingdom DNA and Gene Chip, by Offerings USD Million (2017-2022)
  • Table 95. Netherlands DNA and Gene Chip, by Type USD Million (2017-2022)
  • Table 96. Netherlands DNA and Gene Chip, by Application USD Million (2017-2022)
  • Table 97. Netherlands DNA and Gene Chip, by End Users USD Million (2017-2022)
  • Table 98. Netherlands DNA and Gene Chip, by Offerings USD Million (2017-2022)
  • Table 99. Rest of Europe DNA and Gene Chip, by Type USD Million (2017-2022)
  • Table 100. Rest of Europe DNA and Gene Chip, by Application USD Million (2017-2022)
  • Table 101. Rest of Europe DNA and Gene Chip, by End Users USD Million (2017-2022)
  • Table 102. Rest of Europe DNA and Gene Chip, by Offerings USD Million (2017-2022)
  • Table 103. MEA DNA and Gene Chip, by Country USD Million (2017-2022)
  • Table 104. MEA DNA and Gene Chip, by Type USD Million (2017-2022)
  • Table 105. MEA DNA and Gene Chip, by Application USD Million (2017-2022)
  • Table 106. MEA DNA and Gene Chip, by End Users USD Million (2017-2022)
  • Table 107. MEA DNA and Gene Chip, by Offerings USD Million (2017-2022)
  • Table 108. Middle East DNA and Gene Chip, by Type USD Million (2017-2022)
  • Table 109. Middle East DNA and Gene Chip, by Application USD Million (2017-2022)
  • Table 110. Middle East DNA and Gene Chip, by End Users USD Million (2017-2022)
  • Table 111. Middle East DNA and Gene Chip, by Offerings USD Million (2017-2022)
  • Table 112. Africa DNA and Gene Chip, by Type USD Million (2017-2022)
  • Table 113. Africa DNA and Gene Chip, by Application USD Million (2017-2022)
  • Table 114. Africa DNA and Gene Chip, by End Users USD Million (2017-2022)
  • Table 115. Africa DNA and Gene Chip, by Offerings USD Million (2017-2022)
  • Table 116. North America DNA and Gene Chip, by Country USD Million (2017-2022)
  • Table 117. North America DNA and Gene Chip, by Type USD Million (2017-2022)
  • Table 118. North America DNA and Gene Chip, by Application USD Million (2017-2022)
  • Table 119. North America DNA and Gene Chip, by End Users USD Million (2017-2022)
  • Table 120. North America DNA and Gene Chip, by Offerings USD Million (2017-2022)
  • Table 121. United States DNA and Gene Chip, by Type USD Million (2017-2022)
  • Table 122. United States DNA and Gene Chip, by Application USD Million (2017-2022)
  • Table 123. United States DNA and Gene Chip, by End Users USD Million (2017-2022)
  • Table 124. United States DNA and Gene Chip, by Offerings USD Million (2017-2022)
  • Table 125. Canada DNA and Gene Chip, by Type USD Million (2017-2022)
  • Table 126. Canada DNA and Gene Chip, by Application USD Million (2017-2022)
  • Table 127. Canada DNA and Gene Chip, by End Users USD Million (2017-2022)
  • Table 128. Canada DNA and Gene Chip, by Offerings USD Million (2017-2022)
  • Table 129. Mexico DNA and Gene Chip, by Type USD Million (2017-2022)
  • Table 130. Mexico DNA and Gene Chip, by Application USD Million (2017-2022)
  • Table 131. Mexico DNA and Gene Chip, by End Users USD Million (2017-2022)
  • Table 132. Mexico DNA and Gene Chip, by Offerings USD Million (2017-2022)
  • Table 133. DNA and Gene Chip Sales: by Type(K Units)
  • Table 134. DNA and Gene Chip Sales Oligonucleotide Based Chips {Photolithographic Oligonucleotide Chips, Inkjet Print Technology Generated Oligonucleotide Chips} , by Region K Units (2017-2022)
  • Table 135. DNA and Gene Chip Sales CDNA Chips {Mechanical Microspotting Generated cDNA Chips, Inkjet Print Technology Generated cDNA Chips} , by Region K Units (2017-2022)
  • Table 136. DNA and Gene Chip Sales: by Application(K Units)
  • Table 137. DNA and Gene Chip Sales Gene Expression , by Region K Units (2017-2022)
  • Table 138. DNA and Gene Chip Sales SNP Analysis , by Region K Units (2017-2022)
  • Table 139. DNA and Gene Chip Sales Cancer Diagnosis & Treatment , by Region K Units (2017-2022)
  • Table 140. DNA and Gene Chip Sales Genomics , by Region K Units (2017-2022)
  • Table 141. DNA and Gene Chip Sales Proteomics , by Region K Units (2017-2022)
  • Table 142. DNA and Gene Chip Sales Agricultural Biology , by Region K Units (2017-2022)
  • Table 143. DNA and Gene Chip Sales Environmental Control , by Region K Units (2017-2022)
  • Table 144. DNA and Gene Chip Sales Toxicogenomics , by Region K Units (2017-2022)
  • Table 145. DNA and Gene Chip Sales Drug Discovery , by Region K Units (2017-2022)
  • Table 146. DNA and Gene Chip Sales Screening & Monitoring of Patient Data in Clinical Trials , by Region K Units (2017-2022)
  • Table 147. DNA and Gene Chip Sales Microbial Genotyping , by Region K Units (2017-2022)
  • Table 148. DNA and Gene Chip Sales: by End Users(K Units)
  • Table 149. DNA and Gene Chip Sales Academic & Research Institutes , by Region K Units (2017-2022)
  • Table 150. DNA and Gene Chip Sales Biotechnological & Pharmaceutical Companies , by Region K Units (2017-2022)
  • Table 151. DNA and Gene Chip Sales Research Laboratories , by Region K Units (2017-2022)
  • Table 152. DNA and Gene Chip Sales: by Offerings(K Units)
  • Table 153. DNA and Gene Chip Sales Instruments , by Region K Units (2017-2022)
  • Table 154. DNA and Gene Chip Sales Software , by Region K Units (2017-2022)
  • Table 155. DNA and Gene Chip Sales Others , by Region K Units (2017-2022)
  • Table 156. South America DNA and Gene Chip Sales, by Country K Units (2017-2022)
  • Table 157. South America DNA and Gene Chip Sales, by Type K Units (2017-2022)
  • Table 158. South America DNA and Gene Chip Sales, by Application K Units (2017-2022)
  • Table 159. South America DNA and Gene Chip Sales, by End Users K Units (2017-2022)
  • Table 160. South America DNA and Gene Chip Sales, by Offerings K Units (2017-2022)
  • Table 161. Brazil DNA and Gene Chip Sales, by Type K Units (2017-2022)
  • Table 162. Brazil DNA and Gene Chip Sales, by Application K Units (2017-2022)
  • Table 163. Brazil DNA and Gene Chip Sales, by End Users K Units (2017-2022)
  • Table 164. Brazil DNA and Gene Chip Sales, by Offerings K Units (2017-2022)
  • Table 165. Argentina DNA and Gene Chip Sales, by Type K Units (2017-2022)
  • Table 166. Argentina DNA and Gene Chip Sales, by Application K Units (2017-2022)
  • Table 167. Argentina DNA and Gene Chip Sales, by End Users K Units (2017-2022)
  • Table 168. Argentina DNA and Gene Chip Sales, by Offerings K Units (2017-2022)
  • Table 169. Rest of South America DNA and Gene Chip Sales, by Type K Units (2017-2022)
  • Table 170. Rest of South America DNA and Gene Chip Sales, by Application K Units (2017-2022)
  • Table 171. Rest of South America DNA and Gene Chip Sales, by End Users K Units (2017-2022)
  • Table 172. Rest of South America DNA and Gene Chip Sales, by Offerings K Units (2017-2022)
  • Table 173. Asia Pacific DNA and Gene Chip Sales, by Country K Units (2017-2022)
  • Table 174. Asia Pacific DNA and Gene Chip Sales, by Type K Units (2017-2022)
  • Table 175. Asia Pacific DNA and Gene Chip Sales, by Application K Units (2017-2022)
  • Table 176. Asia Pacific DNA and Gene Chip Sales, by End Users K Units (2017-2022)
  • Table 177. Asia Pacific DNA and Gene Chip Sales, by Offerings K Units (2017-2022)
  • Table 178. China DNA and Gene Chip Sales, by Type K Units (2017-2022)
  • Table 179. China DNA and Gene Chip Sales, by Application K Units (2017-2022)
  • Table 180. China DNA and Gene Chip Sales, by End Users K Units (2017-2022)
  • Table 181. China DNA and Gene Chip Sales, by Offerings K Units (2017-2022)
  • Table 182. Japan DNA and Gene Chip Sales, by Type K Units (2017-2022)
  • Table 183. Japan DNA and Gene Chip Sales, by Application K Units (2017-2022)
  • Table 184. Japan DNA and Gene Chip Sales, by End Users K Units (2017-2022)
  • Table 185. Japan DNA and Gene Chip Sales, by Offerings K Units (2017-2022)
  • Table 186. India DNA and Gene Chip Sales, by Type K Units (2017-2022)
  • Table 187. India DNA and Gene Chip Sales, by Application K Units (2017-2022)
  • Table 188. India DNA and Gene Chip Sales, by End Users K Units (2017-2022)
  • Table 189. India DNA and Gene Chip Sales, by Offerings K Units (2017-2022)
  • Table 190. South Korea DNA and Gene Chip Sales, by Type K Units (2017-2022)
  • Table 191. South Korea DNA and Gene Chip Sales, by Application K Units (2017-2022)
  • Table 192. South Korea DNA and Gene Chip Sales, by End Users K Units (2017-2022)
  • Table 193. South Korea DNA and Gene Chip Sales, by Offerings K Units (2017-2022)
  • Table 194. Taiwan DNA and Gene Chip Sales, by Type K Units (2017-2022)
  • Table 195. Taiwan DNA and Gene Chip Sales, by Application K Units (2017-2022)
  • Table 196. Taiwan DNA and Gene Chip Sales, by End Users K Units (2017-2022)
  • Table 197. Taiwan DNA and Gene Chip Sales, by Offerings K Units (2017-2022)
  • Table 198. Australia DNA and Gene Chip Sales, by Type K Units (2017-2022)
  • Table 199. Australia DNA and Gene Chip Sales, by Application K Units (2017-2022)
  • Table 200. Australia DNA and Gene Chip Sales, by End Users K Units (2017-2022)
  • Table 201. Australia DNA and Gene Chip Sales, by Offerings K Units (2017-2022)
  • Table 202. Rest of Asia-Pacific DNA and Gene Chip Sales, by Type K Units (2017-2022)
  • Table 203. Rest of Asia-Pacific DNA and Gene Chip Sales, by Application K Units (2017-2022)
  • Table 204. Rest of Asia-Pacific DNA and Gene Chip Sales, by End Users K Units (2017-2022)
  • Table 205. Rest of Asia-Pacific DNA and Gene Chip Sales, by Offerings K Units (2017-2022)
  • Table 206. Europe DNA and Gene Chip Sales, by Country K Units (2017-2022)
  • Table 207. Europe DNA and Gene Chip Sales, by Type K Units (2017-2022)
  • Table 208. Europe DNA and Gene Chip Sales, by Application K Units (2017-2022)
  • Table 209. Europe DNA and Gene Chip Sales, by End Users K Units (2017-2022)
  • Table 210. Europe DNA and Gene Chip Sales, by Offerings K Units (2017-2022)
  • Table 211. Germany DNA and Gene Chip Sales, by Type K Units (2017-2022)
  • Table 212. Germany DNA and Gene Chip Sales, by Application K Units (2017-2022)
  • Table 213. Germany DNA and Gene Chip Sales, by End Users K Units (2017-2022)
  • Table 214. Germany DNA and Gene Chip Sales, by Offerings K Units (2017-2022)
  • Table 215. France DNA and Gene Chip Sales, by Type K Units (2017-2022)
  • Table 216. France DNA and Gene Chip Sales, by Application K Units (2017-2022)
  • Table 217. France DNA and Gene Chip Sales, by End Users K Units (2017-2022)
  • Table 218. France DNA and Gene Chip Sales, by Offerings K Units (2017-2022)
  • Table 219. Italy DNA and Gene Chip Sales, by Type K Units (2017-2022)
  • Table 220. Italy DNA and Gene Chip Sales, by Application K Units (2017-2022)
  • Table 221. Italy DNA and Gene Chip Sales, by End Users K Units (2017-2022)
  • Table 222. Italy DNA and Gene Chip Sales, by Offerings K Units (2017-2022)
  • Table 223. United Kingdom DNA and Gene Chip Sales, by Type K Units (2017-2022)
  • Table 224. United Kingdom DNA and Gene Chip Sales, by Application K Units (2017-2022)
  • Table 225. United Kingdom DNA and Gene Chip Sales, by End Users K Units (2017-2022)
  • Table 226. United Kingdom DNA and Gene Chip Sales, by Offerings K Units (2017-2022)
  • Table 227. Netherlands DNA and Gene Chip Sales, by Type K Units (2017-2022)
  • Table 228. Netherlands DNA and Gene Chip Sales, by Application K Units (2017-2022)
  • Table 229. Netherlands DNA and Gene Chip Sales, by End Users K Units (2017-2022)
  • Table 230. Netherlands DNA and Gene Chip Sales, by Offerings K Units (2017-2022)
  • Table 231. Rest of Europe DNA and Gene Chip Sales, by Type K Units (2017-2022)
  • Table 232. Rest of Europe DNA and Gene Chip Sales, by Application K Units (2017-2022)
  • Table 233. Rest of Europe DNA and Gene Chip Sales, by End Users K Units (2017-2022)
  • Table 234. Rest of Europe DNA and Gene Chip Sales, by Offerings K Units (2017-2022)
  • Table 235. MEA DNA and Gene Chip Sales, by Country K Units (2017-2022)
  • Table 236. MEA DNA and Gene Chip Sales, by Type K Units (2017-2022)
  • Table 237. MEA DNA and Gene Chip Sales, by Application K Units (2017-2022)
  • Table 238. MEA DNA and Gene Chip Sales, by End Users K Units (2017-2022)
  • Table 239. MEA DNA and Gene Chip Sales, by Offerings K Units (2017-2022)
  • Table 240. Middle East DNA and Gene Chip Sales, by Type K Units (2017-2022)
  • Table 241. Middle East DNA and Gene Chip Sales, by Application K Units (2017-2022)
  • Table 242. Middle East DNA and Gene Chip Sales, by End Users K Units (2017-2022)
  • Table 243. Middle East DNA and Gene Chip Sales, by Offerings K Units (2017-2022)
  • Table 244. Africa DNA and Gene Chip Sales, by Type K Units (2017-2022)
  • Table 245. Africa DNA and Gene Chip Sales, by Application K Units (2017-2022)
  • Table 246. Africa DNA and Gene Chip Sales, by End Users K Units (2017-2022)
  • Table 247. Africa DNA and Gene Chip Sales, by Offerings K Units (2017-2022)
  • Table 248. North America DNA and Gene Chip Sales, by Country K Units (2017-2022)
  • Table 249. North America DNA and Gene Chip Sales, by Type K Units (2017-2022)
  • Table 250. North America DNA and Gene Chip Sales, by Application K Units (2017-2022)
  • Table 251. North America DNA and Gene Chip Sales, by End Users K Units (2017-2022)
  • Table 252. North America DNA and Gene Chip Sales, by Offerings K Units (2017-2022)
  • Table 253. United States DNA and Gene Chip Sales, by Type K Units (2017-2022)
  • Table 254. United States DNA and Gene Chip Sales, by Application K Units (2017-2022)
  • Table 255. United States DNA and Gene Chip Sales, by End Users K Units (2017-2022)
  • Table 256. United States DNA and Gene Chip Sales, by Offerings K Units (2017-2022)
  • Table 257. Canada DNA and Gene Chip Sales, by Type K Units (2017-2022)
  • Table 258. Canada DNA and Gene Chip Sales, by Application K Units (2017-2022)
  • Table 259. Canada DNA and Gene Chip Sales, by End Users K Units (2017-2022)
  • Table 260. Canada DNA and Gene Chip Sales, by Offerings K Units (2017-2022)
  • Table 261. Mexico DNA and Gene Chip Sales, by Type K Units (2017-2022)
  • Table 262. Mexico DNA and Gene Chip Sales, by Application K Units (2017-2022)
  • Table 263. Mexico DNA and Gene Chip Sales, by End Users K Units (2017-2022)
  • Table 264. Mexico DNA and Gene Chip Sales, by Offerings K Units (2017-2022)
  • Table 265. DNA and Gene Chip: by Type(USD/Units)
  • Table 266. Company Basic Information, Sales Area and Its Competitors
  • Table 267. Company Basic Information, Sales Area and Its Competitors
  • Table 268. Company Basic Information, Sales Area and Its Competitors
  • Table 269. Company Basic Information, Sales Area and Its Competitors
  • Table 270. Company Basic Information, Sales Area and Its Competitors
  • Table 271. Company Basic Information, Sales Area and Its Competitors
  • Table 272. Company Basic Information, Sales Area and Its Competitors
  • Table 273. Company Basic Information, Sales Area and Its Competitors
  • Table 274. Company Basic Information, Sales Area and Its Competitors
  • Table 275. Company Basic Information, Sales Area and Its Competitors
  • Table 276. DNA and Gene Chip: by Type(USD Million)
  • Table 277. DNA and Gene Chip Oligonucleotide Based Chips {Photolithographic Oligonucleotide Chips, Inkjet Print Technology Generated Oligonucleotide Chips} , by Region USD Million (2023-2028)
  • Table 278. DNA and Gene Chip CDNA Chips {Mechanical Microspotting Generated cDNA Chips, Inkjet Print Technology Generated cDNA Chips} , by Region USD Million (2023-2028)
  • Table 279. DNA and Gene Chip: by Application(USD Million)
  • Table 280. DNA and Gene Chip Gene Expression , by Region USD Million (2023-2028)
  • Table 281. DNA and Gene Chip SNP Analysis , by Region USD Million (2023-2028)
  • Table 282. DNA and Gene Chip Cancer Diagnosis & Treatment , by Region USD Million (2023-2028)
  • Table 283. DNA and Gene Chip Genomics , by Region USD Million (2023-2028)
  • Table 284. DNA and Gene Chip Proteomics , by Region USD Million (2023-2028)
  • Table 285. DNA and Gene Chip Agricultural Biology , by Region USD Million (2023-2028)
  • Table 286. DNA and Gene Chip Environmental Control , by Region USD Million (2023-2028)
  • Table 287. DNA and Gene Chip Toxicogenomics , by Region USD Million (2023-2028)
  • Table 288. DNA and Gene Chip Drug Discovery , by Region USD Million (2023-2028)
  • Table 289. DNA and Gene Chip Screening & Monitoring of Patient Data in Clinical Trials , by Region USD Million (2023-2028)
  • Table 290. DNA and Gene Chip Microbial Genotyping , by Region USD Million (2023-2028)
  • Table 291. DNA and Gene Chip: by End Users(USD Million)
  • Table 292. DNA and Gene Chip Academic & Research Institutes , by Region USD Million (2023-2028)
  • Table 293. DNA and Gene Chip Biotechnological & Pharmaceutical Companies , by Region USD Million (2023-2028)
  • Table 294. DNA and Gene Chip Research Laboratories , by Region USD Million (2023-2028)
  • Table 295. DNA and Gene Chip: by Offerings(USD Million)
  • Table 296. DNA and Gene Chip Instruments , by Region USD Million (2023-2028)
  • Table 297. DNA and Gene Chip Software , by Region USD Million (2023-2028)
  • Table 298. DNA and Gene Chip Others , by Region USD Million (2023-2028)
  • Table 299. South America DNA and Gene Chip, by Country USD Million (2023-2028)
  • Table 300. South America DNA and Gene Chip, by Type USD Million (2023-2028)
  • Table 301. South America DNA and Gene Chip, by Application USD Million (2023-2028)
  • Table 302. South America DNA and Gene Chip, by End Users USD Million (2023-2028)
  • Table 303. South America DNA and Gene Chip, by Offerings USD Million (2023-2028)
  • Table 304. Brazil DNA and Gene Chip, by Type USD Million (2023-2028)
  • Table 305. Brazil DNA and Gene Chip, by Application USD Million (2023-2028)
  • Table 306. Brazil DNA and Gene Chip, by End Users USD Million (2023-2028)
  • Table 307. Brazil DNA and Gene Chip, by Offerings USD Million (2023-2028)
  • Table 308. Argentina DNA and Gene Chip, by Type USD Million (2023-2028)
  • Table 309. Argentina DNA and Gene Chip, by Application USD Million (2023-2028)
  • Table 310. Argentina DNA and Gene Chip, by End Users USD Million (2023-2028)
  • Table 311. Argentina DNA and Gene Chip, by Offerings USD Million (2023-2028)
  • Table 312. Rest of South America DNA and Gene Chip, by Type USD Million (2023-2028)
  • Table 313. Rest of South America DNA and Gene Chip, by Application USD Million (2023-2028)
  • Table 314. Rest of South America DNA and Gene Chip, by End Users USD Million (2023-2028)
  • Table 315. Rest of South America DNA and Gene Chip, by Offerings USD Million (2023-2028)
  • Table 316. Asia Pacific DNA and Gene Chip, by Country USD Million (2023-2028)
  • Table 317. Asia Pacific DNA and Gene Chip, by Type USD Million (2023-2028)
  • Table 318. Asia Pacific DNA and Gene Chip, by Application USD Million (2023-2028)
  • Table 319. Asia Pacific DNA and Gene Chip, by End Users USD Million (2023-2028)
  • Table 320. Asia Pacific DNA and Gene Chip, by Offerings USD Million (2023-2028)
  • Table 321. China DNA and Gene Chip, by Type USD Million (2023-2028)
  • Table 322. China DNA and Gene Chip, by Application USD Million (2023-2028)
  • Table 323. China DNA and Gene Chip, by End Users USD Million (2023-2028)
  • Table 324. China DNA and Gene Chip, by Offerings USD Million (2023-2028)
  • Table 325. Japan DNA and Gene Chip, by Type USD Million (2023-2028)
  • Table 326. Japan DNA and Gene Chip, by Application USD Million (2023-2028)
  • Table 327. Japan DNA and Gene Chip, by End Users USD Million (2023-2028)
  • Table 328. Japan DNA and Gene Chip, by Offerings USD Million (2023-2028)
  • Table 329. India DNA and Gene Chip, by Type USD Million (2023-2028)
  • Table 330. India DNA and Gene Chip, by Application USD Million (2023-2028)
  • Table 331. India DNA and Gene Chip, by End Users USD Million (2023-2028)
  • Table 332. India DNA and Gene Chip, by Offerings USD Million (2023-2028)
  • Table 333. South Korea DNA and Gene Chip, by Type USD Million (2023-2028)
  • Table 334. South Korea DNA and Gene Chip, by Application USD Million (2023-2028)
  • Table 335. South Korea DNA and Gene Chip, by End Users USD Million (2023-2028)
  • Table 336. South Korea DNA and Gene Chip, by Offerings USD Million (2023-2028)
  • Table 337. Taiwan DNA and Gene Chip, by Type USD Million (2023-2028)
  • Table 338. Taiwan DNA and Gene Chip, by Application USD Million (2023-2028)
  • Table 339. Taiwan DNA and Gene Chip, by End Users USD Million (2023-2028)
  • Table 340. Taiwan DNA and Gene Chip, by Offerings USD Million (2023-2028)
  • Table 341. Australia DNA and Gene Chip, by Type USD Million (2023-2028)
  • Table 342. Australia DNA and Gene Chip, by Application USD Million (2023-2028)
  • Table 343. Australia DNA and Gene Chip, by End Users USD Million (2023-2028)
  • Table 344. Australia DNA and Gene Chip, by Offerings USD Million (2023-2028)
  • Table 345. Rest of Asia-Pacific DNA and Gene Chip, by Type USD Million (2023-2028)
  • Table 346. Rest of Asia-Pacific DNA and Gene Chip, by Application USD Million (2023-2028)
  • Table 347. Rest of Asia-Pacific DNA and Gene Chip, by End Users USD Million (2023-2028)
  • Table 348. Rest of Asia-Pacific DNA and Gene Chip, by Offerings USD Million (2023-2028)
  • Table 349. Europe DNA and Gene Chip, by Country USD Million (2023-2028)
  • Table 350. Europe DNA and Gene Chip, by Type USD Million (2023-2028)
  • Table 351. Europe DNA and Gene Chip, by Application USD Million (2023-2028)
  • Table 352. Europe DNA and Gene Chip, by End Users USD Million (2023-2028)
  • Table 353. Europe DNA and Gene Chip, by Offerings USD Million (2023-2028)
  • Table 354. Germany DNA and Gene Chip, by Type USD Million (2023-2028)
  • Table 355. Germany DNA and Gene Chip, by Application USD Million (2023-2028)
  • Table 356. Germany DNA and Gene Chip, by End Users USD Million (2023-2028)
  • Table 357. Germany DNA and Gene Chip, by Offerings USD Million (2023-2028)
  • Table 358. France DNA and Gene Chip, by Type USD Million (2023-2028)
  • Table 359. France DNA and Gene Chip, by Application USD Million (2023-2028)
  • Table 360. France DNA and Gene Chip, by End Users USD Million (2023-2028)
  • Table 361. France DNA and Gene Chip, by Offerings USD Million (2023-2028)
  • Table 362. Italy DNA and Gene Chip, by Type USD Million (2023-2028)
  • Table 363. Italy DNA and Gene Chip, by Application USD Million (2023-2028)
  • Table 364. Italy DNA and Gene Chip, by End Users USD Million (2023-2028)
  • Table 365. Italy DNA and Gene Chip, by Offerings USD Million (2023-2028)
  • Table 366. United Kingdom DNA and Gene Chip, by Type USD Million (2023-2028)
  • Table 367. United Kingdom DNA and Gene Chip, by Application USD Million (2023-2028)
  • Table 368. United Kingdom DNA and Gene Chip, by End Users USD Million (2023-2028)
  • Table 369. United Kingdom DNA and Gene Chip, by Offerings USD Million (2023-2028)
  • Table 370. Netherlands DNA and Gene Chip, by Type USD Million (2023-2028)
  • Table 371. Netherlands DNA and Gene Chip, by Application USD Million (2023-2028)
  • Table 372. Netherlands DNA and Gene Chip, by End Users USD Million (2023-2028)
  • Table 373. Netherlands DNA and Gene Chip, by Offerings USD Million (2023-2028)
  • Table 374. Rest of Europe DNA and Gene Chip, by Type USD Million (2023-2028)
  • Table 375. Rest of Europe DNA and Gene Chip, by Application USD Million (2023-2028)
  • Table 376. Rest of Europe DNA and Gene Chip, by End Users USD Million (2023-2028)
  • Table 377. Rest of Europe DNA and Gene Chip, by Offerings USD Million (2023-2028)
  • Table 378. MEA DNA and Gene Chip, by Country USD Million (2023-2028)
  • Table 379. MEA DNA and Gene Chip, by Type USD Million (2023-2028)
  • Table 380. MEA DNA and Gene Chip, by Application USD Million (2023-2028)
  • Table 381. MEA DNA and Gene Chip, by End Users USD Million (2023-2028)
  • Table 382. MEA DNA and Gene Chip, by Offerings USD Million (2023-2028)
  • Table 383. Middle East DNA and Gene Chip, by Type USD Million (2023-2028)
  • Table 384. Middle East DNA and Gene Chip, by Application USD Million (2023-2028)
  • Table 385. Middle East DNA and Gene Chip, by End Users USD Million (2023-2028)
  • Table 386. Middle East DNA and Gene Chip, by Offerings USD Million (2023-2028)
  • Table 387. Africa DNA and Gene Chip, by Type USD Million (2023-2028)
  • Table 388. Africa DNA and Gene Chip, by Application USD Million (2023-2028)
  • Table 389. Africa DNA and Gene Chip, by End Users USD Million (2023-2028)
  • Table 390. Africa DNA and Gene Chip, by Offerings USD Million (2023-2028)
  • Table 391. North America DNA and Gene Chip, by Country USD Million (2023-2028)
  • Table 392. North America DNA and Gene Chip, by Type USD Million (2023-2028)
  • Table 393. North America DNA and Gene Chip, by Application USD Million (2023-2028)
  • Table 394. North America DNA and Gene Chip, by End Users USD Million (2023-2028)
  • Table 395. North America DNA and Gene Chip, by Offerings USD Million (2023-2028)
  • Table 396. United States DNA and Gene Chip, by Type USD Million (2023-2028)
  • Table 397. United States DNA and Gene Chip, by Application USD Million (2023-2028)
  • Table 398. United States DNA and Gene Chip, by End Users USD Million (2023-2028)
  • Table 399. United States DNA and Gene Chip, by Offerings USD Million (2023-2028)
  • Table 400. Canada DNA and Gene Chip, by Type USD Million (2023-2028)
  • Table 401. Canada DNA and Gene Chip, by Application USD Million (2023-2028)
  • Table 402. Canada DNA and Gene Chip, by End Users USD Million (2023-2028)
  • Table 403. Canada DNA and Gene Chip, by Offerings USD Million (2023-2028)
  • Table 404. Mexico DNA and Gene Chip, by Type USD Million (2023-2028)
  • Table 405. Mexico DNA and Gene Chip, by Application USD Million (2023-2028)
  • Table 406. Mexico DNA and Gene Chip, by End Users USD Million (2023-2028)
  • Table 407. Mexico DNA and Gene Chip, by Offerings USD Million (2023-2028)
  • Table 408. DNA and Gene Chip Sales: by Type(K Units)
  • Table 409. DNA and Gene Chip Sales Oligonucleotide Based Chips {Photolithographic Oligonucleotide Chips, Inkjet Print Technology Generated Oligonucleotide Chips} , by Region K Units (2023-2028)
  • Table 410. DNA and Gene Chip Sales CDNA Chips {Mechanical Microspotting Generated cDNA Chips, Inkjet Print Technology Generated cDNA Chips} , by Region K Units (2023-2028)
  • Table 411. DNA and Gene Chip Sales: by Application(K Units)
  • Table 412. DNA and Gene Chip Sales Gene Expression , by Region K Units (2023-2028)
  • Table 413. DNA and Gene Chip Sales SNP Analysis , by Region K Units (2023-2028)
  • Table 414. DNA and Gene Chip Sales Cancer Diagnosis & Treatment , by Region K Units (2023-2028)
  • Table 415. DNA and Gene Chip Sales Genomics , by Region K Units (2023-2028)
  • Table 416. DNA and Gene Chip Sales Proteomics , by Region K Units (2023-2028)
  • Table 417. DNA and Gene Chip Sales Agricultural Biology , by Region K Units (2023-2028)
  • Table 418. DNA and Gene Chip Sales Environmental Control , by Region K Units (2023-2028)
  • Table 419. DNA and Gene Chip Sales Toxicogenomics , by Region K Units (2023-2028)
  • Table 420. DNA and Gene Chip Sales Drug Discovery , by Region K Units (2023-2028)
  • Table 421. DNA and Gene Chip Sales Screening & Monitoring of Patient Data in Clinical Trials , by Region K Units (2023-2028)
  • Table 422. DNA and Gene Chip Sales Microbial Genotyping , by Region K Units (2023-2028)
  • Table 423. DNA and Gene Chip Sales: by End Users(K Units)
  • Table 424. DNA and Gene Chip Sales Academic & Research Institutes , by Region K Units (2023-2028)
  • Table 425. DNA and Gene Chip Sales Biotechnological & Pharmaceutical Companies , by Region K Units (2023-2028)
  • Table 426. DNA and Gene Chip Sales Research Laboratories , by Region K Units (2023-2028)
  • Table 427. DNA and Gene Chip Sales: by Offerings(K Units)
  • Table 428. DNA and Gene Chip Sales Instruments , by Region K Units (2023-2028)
  • Table 429. DNA and Gene Chip Sales Software , by Region K Units (2023-2028)
  • Table 430. DNA and Gene Chip Sales Others , by Region K Units (2023-2028)
  • Table 431. South America DNA and Gene Chip Sales, by Country K Units (2023-2028)
  • Table 432. South America DNA and Gene Chip Sales, by Type K Units (2023-2028)
  • Table 433. South America DNA and Gene Chip Sales, by Application K Units (2023-2028)
  • Table 434. South America DNA and Gene Chip Sales, by End Users K Units (2023-2028)
  • Table 435. South America DNA and Gene Chip Sales, by Offerings K Units (2023-2028)
  • Table 436. Brazil DNA and Gene Chip Sales, by Type K Units (2023-2028)
  • Table 437. Brazil DNA and Gene Chip Sales, by Application K Units (2023-2028)
  • Table 438. Brazil DNA and Gene Chip Sales, by End Users K Units (2023-2028)
  • Table 439. Brazil DNA and Gene Chip Sales, by Offerings K Units (2023-2028)
  • Table 440. Argentina DNA and Gene Chip Sales, by Type K Units (2023-2028)
  • Table 441. Argentina DNA and Gene Chip Sales, by Application K Units (2023-2028)
  • Table 442. Argentina DNA and Gene Chip Sales, by End Users K Units (2023-2028)
  • Table 443. Argentina DNA and Gene Chip Sales, by Offerings K Units (2023-2028)
  • Table 444. Rest of South America DNA and Gene Chip Sales, by Type K Units (2023-2028)
  • Table 445. Rest of South America DNA and Gene Chip Sales, by Application K Units (2023-2028)
  • Table 446. Rest of South America DNA and Gene Chip Sales, by End Users K Units (2023-2028)
  • Table 447. Rest of South America DNA and Gene Chip Sales, by Offerings K Units (2023-2028)
  • Table 448. Asia Pacific DNA and Gene Chip Sales, by Country K Units (2023-2028)
  • Table 449. Asia Pacific DNA and Gene Chip Sales, by Type K Units (2023-2028)
  • Table 450. Asia Pacific DNA and Gene Chip Sales, by Application K Units (2023-2028)
  • Table 451. Asia Pacific DNA and Gene Chip Sales, by End Users K Units (2023-2028)
  • Table 452. Asia Pacific DNA and Gene Chip Sales, by Offerings K Units (2023-2028)
  • Table 453. China DNA and Gene Chip Sales, by Type K Units (2023-2028)
  • Table 454. China DNA and Gene Chip Sales, by Application K Units (2023-2028)
  • Table 455. China DNA and Gene Chip Sales, by End Users K Units (2023-2028)
  • Table 456. China DNA and Gene Chip Sales, by Offerings K Units (2023-2028)
  • Table 457. Japan DNA and Gene Chip Sales, by Type K Units (2023-2028)
  • Table 458. Japan DNA and Gene Chip Sales, by Application K Units (2023-2028)
  • Table 459. Japan DNA and Gene Chip Sales, by End Users K Units (2023-2028)
  • Table 460. Japan DNA and Gene Chip Sales, by Offerings K Units (2023-2028)
  • Table 461. India DNA and Gene Chip Sales, by Type K Units (2023-2028)
  • Table 462. India DNA and Gene Chip Sales, by Application K Units (2023-2028)
  • Table 463. India DNA and Gene Chip Sales, by End Users K Units (2023-2028)
  • Table 464. India DNA and Gene Chip Sales, by Offerings K Units (2023-2028)
  • Table 465. South Korea DNA and Gene Chip Sales, by Type K Units (2023-2028)
  • Table 466. South Korea DNA and Gene Chip Sales, by Application K Units (2023-2028)
  • Table 467. South Korea DNA and Gene Chip Sales, by End Users K Units (2023-2028)
  • Table 468. South Korea DNA and Gene Chip Sales, by Offerings K Units (2023-2028)
  • Table 469. Taiwan DNA and Gene Chip Sales, by Type K Units (2023-2028)
  • Table 470. Taiwan DNA and Gene Chip Sales, by Application K Units (2023-2028)
  • Table 471. Taiwan DNA and Gene Chip Sales, by End Users K Units (2023-2028)
  • Table 472. Taiwan DNA and Gene Chip Sales, by Offerings K Units (2023-2028)
  • Table 473. Australia DNA and Gene Chip Sales, by Type K Units (2023-2028)
  • Table 474. Australia DNA and Gene Chip Sales, by Application K Units (2023-2028)
  • Table 475. Australia DNA and Gene Chip Sales, by End Users K Units (2023-2028)
  • Table 476. Australia DNA and Gene Chip Sales, by Offerings K Units (2023-2028)
  • Table 477. Rest of Asia-Pacific DNA and Gene Chip Sales, by Type K Units (2023-2028)
  • Table 478. Rest of Asia-Pacific DNA and Gene Chip Sales, by Application K Units (2023-2028)
  • Table 479. Rest of Asia-Pacific DNA and Gene Chip Sales, by End Users K Units (2023-2028)
  • Table 480. Rest of Asia-Pacific DNA and Gene Chip Sales, by Offerings K Units (2023-2028)
  • Table 481. Europe DNA and Gene Chip Sales, by Country K Units (2023-2028)
  • Table 482. Europe DNA and Gene Chip Sales, by Type K Units (2023-2028)
  • Table 483. Europe DNA and Gene Chip Sales, by Application K Units (2023-2028)
  • Table 484. Europe DNA and Gene Chip Sales, by End Users K Units (2023-2028)
  • Table 485. Europe DNA and Gene Chip Sales, by Offerings K Units (2023-2028)
  • Table 486. Germany DNA and Gene Chip Sales, by Type K Units (2023-2028)
  • Table 487. Germany DNA and Gene Chip Sales, by Application K Units (2023-2028)
  • Table 488. Germany DNA and Gene Chip Sales, by End Users K Units (2023-2028)
  • Table 489. Germany DNA and Gene Chip Sales, by Offerings K Units (2023-2028)
  • Table 490. France DNA and Gene Chip Sales, by Type K Units (2023-2028)
  • Table 491. France DNA and Gene Chip Sales, by Application K Units (2023-2028)
  • Table 492. France DNA and Gene Chip Sales, by End Users K Units (2023-2028)
  • Table 493. France DNA and Gene Chip Sales, by Offerings K Units (2023-2028)
  • Table 494. Italy DNA and Gene Chip Sales, by Type K Units (2023-2028)
  • Table 495. Italy DNA and Gene Chip Sales, by Application K Units (2023-2028)
  • Table 496. Italy DNA and Gene Chip Sales, by End Users K Units (2023-2028)
  • Table 497. Italy DNA and Gene Chip Sales, by Offerings K Units (2023-2028)
  • Table 498. United Kingdom DNA and Gene Chip Sales, by Type K Units (2023-2028)
  • Table 499. United Kingdom DNA and Gene Chip Sales, by Application K Units (2023-2028)
  • Table 500. United Kingdom DNA and Gene Chip Sales, by End Users K Units (2023-2028)
  • Table 501. United Kingdom DNA and Gene Chip Sales, by Offerings K Units (2023-2028)
  • Table 502. Netherlands DNA and Gene Chip Sales, by Type K Units (2023-2028)
  • Table 503. Netherlands DNA and Gene Chip Sales, by Application K Units (2023-2028)
  • Table 504. Netherlands DNA and Gene Chip Sales, by End Users K Units (2023-2028)
  • Table 505. Netherlands DNA and Gene Chip Sales, by Offerings K Units (2023-2028)
  • Table 506. Rest of Europe DNA and Gene Chip Sales, by Type K Units (2023-2028)
  • Table 507. Rest of Europe DNA and Gene Chip Sales, by Application K Units (2023-2028)
  • Table 508. Rest of Europe DNA and Gene Chip Sales, by End Users K Units (2023-2028)
  • Table 509. Rest of Europe DNA and Gene Chip Sales, by Offerings K Units (2023-2028)
  • Table 510. MEA DNA and Gene Chip Sales, by Country K Units (2023-2028)
  • Table 511. MEA DNA and Gene Chip Sales, by Type K Units (2023-2028)
  • Table 512. MEA DNA and Gene Chip Sales, by Application K Units (2023-2028)
  • Table 513. MEA DNA and Gene Chip Sales, by End Users K Units (2023-2028)
  • Table 514. MEA DNA and Gene Chip Sales, by Offerings K Units (2023-2028)
  • Table 515. Middle East DNA and Gene Chip Sales, by Type K Units (2023-2028)
  • Table 516. Middle East DNA and Gene Chip Sales, by Application K Units (2023-2028)
  • Table 517. Middle East DNA and Gene Chip Sales, by End Users K Units (2023-2028)
  • Table 518. Middle East DNA and Gene Chip Sales, by Offerings K Units (2023-2028)
  • Table 519. Africa DNA and Gene Chip Sales, by Type K Units (2023-2028)
  • Table 520. Africa DNA and Gene Chip Sales, by Application K Units (2023-2028)
  • Table 521. Africa DNA and Gene Chip Sales, by End Users K Units (2023-2028)
  • Table 522. Africa DNA and Gene Chip Sales, by Offerings K Units (2023-2028)
  • Table 523. North America DNA and Gene Chip Sales, by Country K Units (2023-2028)
  • Table 524. North America DNA and Gene Chip Sales, by Type K Units (2023-2028)
  • Table 525. North America DNA and Gene Chip Sales, by Application K Units (2023-2028)
  • Table 526. North America DNA and Gene Chip Sales, by End Users K Units (2023-2028)
  • Table 527. North America DNA and Gene Chip Sales, by Offerings K Units (2023-2028)
  • Table 528. United States DNA and Gene Chip Sales, by Type K Units (2023-2028)
  • Table 529. United States DNA and Gene Chip Sales, by Application K Units (2023-2028)
  • Table 530. United States DNA and Gene Chip Sales, by End Users K Units (2023-2028)
  • Table 531. United States DNA and Gene Chip Sales, by Offerings K Units (2023-2028)
  • Table 532. Canada DNA and Gene Chip Sales, by Type K Units (2023-2028)
  • Table 533. Canada DNA and Gene Chip Sales, by Application K Units (2023-2028)
  • Table 534. Canada DNA and Gene Chip Sales, by End Users K Units (2023-2028)
  • Table 535. Canada DNA and Gene Chip Sales, by Offerings K Units (2023-2028)
  • Table 536. Mexico DNA and Gene Chip Sales, by Type K Units (2023-2028)
  • Table 537. Mexico DNA and Gene Chip Sales, by Application K Units (2023-2028)
  • Table 538. Mexico DNA and Gene Chip Sales, by End Users K Units (2023-2028)
  • Table 539. Mexico DNA and Gene Chip Sales, by Offerings K Units (2023-2028)
  • Table 540. DNA and Gene Chip: by Type(USD/Units)
  • Table 541. Research Programs/Design for This Report
  • Table 542. Key Data Information from Secondary Sources
  • Table 543. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global DNA and Gene Chip: by Type USD Million (2017-2022)
  • Figure 5. Global DNA and Gene Chip: by Application USD Million (2017-2022)
  • Figure 6. Global DNA and Gene Chip: by End Users USD Million (2017-2022)
  • Figure 7. Global DNA and Gene Chip: by Offerings USD Million (2017-2022)
  • Figure 8. South America DNA and Gene Chip Share (%), by Country
  • Figure 9. Asia Pacific DNA and Gene Chip Share (%), by Country
  • Figure 10. Europe DNA and Gene Chip Share (%), by Country
  • Figure 11. MEA DNA and Gene Chip Share (%), by Country
  • Figure 12. North America DNA and Gene Chip Share (%), by Country
  • Figure 13. Global DNA and Gene Chip: by Type K Units (2017-2022)
  • Figure 14. Global DNA and Gene Chip: by Application K Units (2017-2022)
  • Figure 15. Global DNA and Gene Chip: by End Users K Units (2017-2022)
  • Figure 16. Global DNA and Gene Chip: by Offerings K Units (2017-2022)
  • Figure 17. South America DNA and Gene Chip Share (%), by Country
  • Figure 18. Asia Pacific DNA and Gene Chip Share (%), by Country
  • Figure 19. Europe DNA and Gene Chip Share (%), by Country
  • Figure 20. MEA DNA and Gene Chip Share (%), by Country
  • Figure 21. North America DNA and Gene Chip Share (%), by Country
  • Figure 22. Global DNA and Gene Chip: by Type USD/Units (2017-2022)
  • Figure 23. Global DNA and Gene Chip share by Players 2022 (%)
  • Figure 24. Global DNA and Gene Chip share by Players (Top 3) 2022(%)
  • Figure 25. Global DNA and Gene Chip share by Players (Top 5) 2022(%)
  • Figure 26. BCG Matrix for key Companies
  • Figure 27. Affymetrix Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Affymetrix Inc. (United States) Revenue: by Geography 2022
  • Figure 29. Agilent Technologies Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 30. Agilent Technologies Inc. (United States) Revenue: by Geography 2022
  • Figure 31. Biomieux Sa (France) Revenue, Net Income and Gross profit
  • Figure 32. Biomieux Sa (France) Revenue: by Geography 2022
  • Figure 33. Biometrix Technology Inc. (Korea) Revenue, Net Income and Gross profit
  • Figure 34. Biometrix Technology Inc. (Korea) Revenue: by Geography 2022
  • Figure 35. Bioneer Corp (South Korea) Revenue, Net Income and Gross profit
  • Figure 36. Bioneer Corp (South Korea) Revenue: by Geography 2022
  • Figure 37. Capitalbio Corp (China) Revenue, Net Income and Gross profit
  • Figure 38. Capitalbio Corp (China) Revenue: by Geography 2022
  • Figure 39. Eurofins Scientific (Eurofins Mwg Operon) (Luxembourg) Revenue, Net Income and Gross profit
  • Figure 40. Eurofins Scientific (Eurofins Mwg Operon) (Luxembourg) Revenue: by Geography 2022
  • Figure 41. Greiner Bio-One (Austria) Revenue, Net Income and Gross profit
  • Figure 42. Greiner Bio-One (Austria) Revenue: by Geography 2022
  • Figure 43. Illumina Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 44. Illumina Inc. (United States) Revenue: by Geography 2022
  • Figure 45. LC Sciences (United States) Revenue, Net Income and Gross profit
  • Figure 46. LC Sciences (United States) Revenue: by Geography 2022
  • Figure 47. Global DNA and Gene Chip: by Type USD Million (2023-2028)
  • Figure 48. Global DNA and Gene Chip: by Application USD Million (2023-2028)
  • Figure 49. Global DNA and Gene Chip: by End Users USD Million (2023-2028)
  • Figure 50. Global DNA and Gene Chip: by Offerings USD Million (2023-2028)
  • Figure 51. South America DNA and Gene Chip Share (%), by Country
  • Figure 52. Asia Pacific DNA and Gene Chip Share (%), by Country
  • Figure 53. Europe DNA and Gene Chip Share (%), by Country
  • Figure 54. MEA DNA and Gene Chip Share (%), by Country
  • Figure 55. North America DNA and Gene Chip Share (%), by Country
  • Figure 56. Global DNA and Gene Chip: by Type K Units (2023-2028)
  • Figure 57. Global DNA and Gene Chip: by Application K Units (2023-2028)
  • Figure 58. Global DNA and Gene Chip: by End Users K Units (2023-2028)
  • Figure 59. Global DNA and Gene Chip: by Offerings K Units (2023-2028)
  • Figure 60. South America DNA and Gene Chip Share (%), by Country
  • Figure 61. Asia Pacific DNA and Gene Chip Share (%), by Country
  • Figure 62. Europe DNA and Gene Chip Share (%), by Country
  • Figure 63. MEA DNA and Gene Chip Share (%), by Country
  • Figure 64. North America DNA and Gene Chip Share (%), by Country
  • Figure 65. Global DNA and Gene Chip: by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • Affymetrix Inc. (United States)
  • Agilent Technologies Inc. (United States)
  • Biomieux Sa (France)
  • Biometrix Technology Inc. (Korea)
  • Bioneer Corp (South Korea)
  • Capitalbio Corp (China)
  • Eurofins Scientific (Eurofins Mwg Operon) (Luxembourg)
  • Greiner Bio-One (Austria)
  • Illumina Inc. (United States)
  • LC Sciences (United States)
Additional players considered in the study are as follows:
Life Technologies Corp. (United States) , Macrogen Inc. (South Korea) , Roche Nimblegen Inc. (United States)
Select User Access Type

Key Highlights of Report


Dec 2023 225 Pages 74 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global DNA and Gene Chip Quantitative research analysis
Global DNA and Gene Chip Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Historical year: 2018-2022; Base year: 2022; Forecast period: 2023 to 2028
Companies that are profiled in Global DNA and Gene Chip Market are Affymetrix Inc. (United States), Agilent Technologies Inc. (United States), Biomieux Sa (France), Biometrix Technology Inc. (Korea), Bioneer Corp (South Korea), Capitalbio Corp (China), Eurofins Scientific (Eurofins Mwg Operon) (Luxembourg), Greiner Bio-One (Austria), Illumina Inc. (United States) and LC Sciences (United States) etc.
Gene Expression segment in Global market to hold robust market share owing to "Increasing Initiatives Related to the DNA or Gene is Driving the Growth of the Market ".
AMA Research predicts that United States Players will contribute to the maximum growth of Global DNA and Gene Chip market throughout the forecasted period.

Know More About Global DNA and Gene Chip Report?

Have a Query? Click Here

Other Related Reports

Extremity Tissue Expander Comprehensive Study by Type (Upper extremities, Lower extremities), Application (Breast reconstruction, Scalp reconstruction, Oral and maxillofacial reconstruction, Paediatr...
$ 3650
Antibiotic Resistance Comprehensive Study by Disease (Complicated Urinary Tract Infection {cUTI}, Complicated Intra-Abdominal Infections {cIAI}, Blood Stream Infections {BSI}, Clostridium difficile i...
$ 3750
BioPharma Buffers Comprehensive Study by Type (Phosphates, Acetates, TRIS, Others), Application (Research Institution, Pharmaceutical Industry, Others), Distribution Channel (Online, Offline), Packag...
$ 3450
Protein Labeling Comprehensive Study by Type (Reagents, Kits, Services), Application (Cell-based Assays, Fluorescence Microscopy, Immunological Techniques, Mass Spectrometry, Protein Microarray), Pro...
$ 3750
Umbilical Cord Blood Banking Comprehensive Study by Application (Cancers, Blood Disorders, Metabolic Disorders, Immune Disorders, Osteopetrosis, Others), Services (Sample Preservation, Analysis, Proc...
$ 3650
Protein Sequencing Comprehensive Study by Type (Reagents & Consumables, Instrument, Analysis Products, Protein Sequencing Service, Others), Application (Biotherapeutics, Genetic Engineering), End Use...
$ 3650